Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $173.2 million versus the consensus estimate of $173.81 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.